This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Master Pharm Balance Sheet Health
Financial Health criteria checks 5/6
Key information
16.1%
Debt to equity ratio
zł13.30m
Debt
Interest coverage ratio | 40.5x |
Cash | zł13.57m |
Equity | zł82.62m |
Total liabilities | zł32.11m |
Total assets | zł114.73m |
Recent financial health updates
No updates
Recent updates
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)
Feb 05Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes
Dec 13A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)
May 25Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends
Mar 30Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease
Feb 04Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?
Jan 08Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital
Dec 18Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 27Financial Position Analysis
Short Term Liabilities: MPH's short term assets (PLN60.0M) exceed its short term liabilities (PLN20.4M).
Long Term Liabilities: MPH's short term assets (PLN60.0M) exceed its long term liabilities (PLN11.7M).
Debt to Equity History and Analysis
Debt Level: MPH has more cash than its total debt.
Reducing Debt: MPH's debt to equity ratio has increased from 0% to 16.1% over the past 5 years.
Debt Coverage: MPH's debt is well covered by operating cash flow (124.6%).
Interest Coverage: MPH's interest payments on its debt are well covered by EBIT (40.5x coverage).